Welcome to our dedicated page for RLI SEC filings (Ticker: RLI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RLI Corp.'s SEC filings document a specialty property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Current reports furnish quarterly and annual earnings releases, analyst-call transcripts under Regulation FD, dividend declarations and material events for the company and its insurance operations.
RLI's filings also cover governance and executive compensation through proxy statements, capital-structure matters such as its senior notes due 2036, and registered security details for its common stock. These disclosures frame the company's Casualty, Property and Surety operations, investment income, underwriting performance, board matters and shareholder voting items.
RLI Corp. reported the results of its annual shareholder meeting. All ten director nominees were elected to the Board for one-year terms, with support levels generally around 75–79 million votes in favor and several million broker non-votes recorded for each nominee.
The Board appointed David B. Duclos as Chairman of the Board following the election. Shareholders also approved, on a non-binding, advisory basis, the compensation of the company’s named executive officers, with 73,994,515 votes for, 4,360,524 against, and 1,971,629 abstentions, plus 5,878,022 broker non-votes.
In addition, shareholders ratified the selection of Deloitte & Touche LLP as RLI’s independent registered public accounting firm for 2026, with 85,861,465 votes for, 219,582 against, and 123,643 abstentions.
RLI Corp’s Chief Operating Officer Jennifer L. Klobnak made an open-market purchase of 2,000 shares of RLI common stock on May 19, 2026 at $53.42 per share. Following this buy, she directly holds 102,318 shares. Footnotes note prior 2-for-1 split adjustments and dividend reinvestment effects on the balance.
RLI CORP reported that Chief Operating Officer Jennifer L. Klobnak received a grant of stock options covering 12,500 shares of RLI common stock. The options have an exercise price of $49.88 per share and expire on May 14, 2034. According to the award schedule, 20% of the aggregate shares become exercisable one year after the grant date and then in 20% increments each year thereafter. Following this compensation-related award, Klobnak holds 12,500 stock options directly.
RLI CORP reported that Vice President and Controller Seth Anthony Davis received new equity awards. On May 14, 2026, he was granted 300 restricted stock units, each representing one share of common stock upon vesting, scheduled to vest 100% on the third anniversary of the grant date. He was also granted stock options on 1,500 shares of common stock at an exercise price of $49.88 per share. According to the option schedule, 20% of the options become exercisable one year from the grant date and an additional 20% each year thereafter.
RLI Corp’s chief legal officer, Jeffrey D. Fick, received a grant of stock options covering 7,500 shares of common stock. The options carry an exercise price of $49.88 per share and expire on May 14, 2034. According to the vesting schedule, 20% of the options become exercisable one year after the grant date, with an additional 20% vesting on each anniversary thereafter until fully vested. This is a compensation-related award rather than an open-market purchase or sale.
RLI CORP reported that Chief Financial Officer Aaron Paul Diefenthaler received a grant of stock options. The award covers 40,000 stock options for RLI common stock at an exercise price of $49.88 per share.
These options were granted as compensation and are exercisable on a schedule where 20% of the total can be exercised beginning one year after the grant date and an additional 20% in each following year. After this grant, Diefenthaler holds 40,000 stock options directly, with the options scheduled to expire on May 14, 2034.
RLI Corp chief executive officer Craig W. Kliethermes reported a compensation-related stock option grant. He received options covering 22,500 shares of common stock at an exercise price of $49.88 per share. The options expire on May 14, 2034 and vest in 20% increments annually, beginning one year after the grant date.
RLI CORP director Clark C. Kellogg reported routine equity compensation and related share movements. He received a grant of 2,506 restricted stock units (RSUs), each representing one share of common stock. These RSUs are scheduled to vest 100% on the earlier of the company’s 2027 annual shareholders’ meeting or one year after grant.
Kellogg also exercised 1,681 previously granted RSUs into 1,681 shares of common stock and, through a Directors' Trust, acquired an additional 68 shares attributable to accrued special and regular dividend equivalents on RSUs. Following these transactions, the Directors' Trust holds 1,749 shares of common stock.
RLI Corp director Paul Bennett reported routine equity compensation and related transactions. He received a grant of 2,506 restricted stock units, which are scheduled to vest 100% on the earlier of the RLI Corp 2027 Annual Shareholders' Meeting or one year after the grant date.
Bennett also exercised 1,681 restricted stock units into an equal number of common shares and now holds 9,096.229 common shares indirectly through a Directors' Trust, with ownership reflecting dividend reinvestment. Following these moves, he holds 2,506 restricted stock units directly and no remaining units from the exercised grant.
RLI CORP director Debbie Sharell Roberts reported routine equity compensation activity. She received a grant of 2,506 restricted stock units (RSUs) on May 14, 2026, which convert into an equal number of RLI common shares when they vest.
The filing shows she exercised 1,681 RSUs into 1,681 shares of common stock on May 13, 2026, fully exhausting that RSU award. After related transactions, a Directors' Trust associated with her holds 28,837.066 common shares, including 68 shares reflecting dividend reinvestment. The new 2,506 RSUs are scheduled to vest 100% at the earlier of the 2026 annual shareholders' meeting or one year from grant.